Sridevi Rajeeve

15PUBLICATIONS
79CO-AUTHORS
Haematological tumoursMedical bacteriologyPredictive and prognostic markersMedical mycologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 29, 2026
Robust CD4+ CAR T cell expansion is associated with non-ICANS neurotoxicities after ciltacabtagene autoleucel in patients with multiple myeloma.

|Jul 20, 2026
Lenalidomide-Related Diarrhea in Patients with Multiple Myeloma Is Associated with Gut Microbiota Dysbiosis and Disruption of the Bile Acid Pool.

|Apr 12, 2026
Functionally high-risk disease is associated with poor outcomes after late-line CAR T-cell therapy for multiple myeloma.

Hamza Hashmi, Tara Sebastian, Sridevi Rajeeve

|Sep 16, 2025
Defining the Rates of Cytokine Release Syndrome Associated With Talquetamab Step-up Doses.

Issam S Hamadeh, Lisa Modelevsky, Amelia Chan

|Aug 25, 2025
Immune MRD Status Informs Tumor MRD Outcome Prognostication in Patients with Multiple Myeloma on Lenalidomide Maintenance.

Ross S Firestone, Anish K Simhal, Devin McAvoy

|Apr 21, 2025
T-ICAHT: grading and prognostic impact of thrombocytopenia after CAR T-cell therapy.

Kai Rejeski, Jaime Sanz, Teng Fei

Pageof 3

Frequent Collaborators

11 joint publications

Sergio Giralt

11 joint publications

Heather Landau

11 joint publications

Kylee Maclachlan

11 joint publications

Urvi Shah